Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Antiparasitics

Set Alert for Antiparasitics

FDA warns of adverse drug events related to isoxazolines

The US FDA is alerting pet owners and veterinarians of the possible adverse neurological events to cats and dogs associated with isoxazoline flea and tick products.

FDA Antiparasitics

New Kansas City company to provide market with revenue-ready products

Covenant Animal Health Partners has been launched to focus on bringing animal health innovations to market.

R&D Companion Animals

Bayer's Seresto collar approved for reducing leishmaniasis transmission

Bayer Animal Health's Seresto flea and tick collar has recently been licensed in several European countries to reduce the risk of canine leishmaniasis.

Europe Bayer Animal Health

Piedmont, Norbrook gain generic approvals for pets and livestock

Piedmont Animal Health and Norbrook Laboratories are among several firms to have gained recent product approvals from the US FDA.

United States Bayer Animal Health

Zoetis seeks 2020 launch for Simparica Trio

Zoetis is aiming to get approval for a new three-way combination parasiticide, with launches penciled in for 2020.

Antiparasitics Zoetis

Zoetis to discontinue sales of equine wormer

Zoetis' Equitape praziquantel-only wormer for horses will be discontinued from the firm's equine product range in October 2018.

United Kingdom Antiparasitics

Boehringer extends Nexgard indications with new approval

Boehringer Ingelheim Animal Health's NexGard antiparasitic chewable tablet for dogs has gained a supplemental approval from the US FDA for the prevention of a bacterial infection.

Boehringer Ingelheim Animal Health Product Approvals

Animal Pharm seeks freelance special reports writers

Animal Pharm is looking for new authors for its animal health industry reports team.

Policy & Regulation Companion Animals

Study outlines crossover potential for vet antiparasitics into human medicine

New research has outlined the potential of repurposing common veterinary antiparasiticides for the control of human vector-borne diseases.

Research Antiparasitics

Animal health focus allows TyraTech to think big with its revenues, pipeline

Last year, TyraTech did the opposite of many companies and offloaded its human health business. Now with a focus on animal health, the Morrisville, North Carolina-based firm can pursue a more disciplined growth strategy. Animal Pharm editor Joseph Harvey spoke to the company's chief executive Bruno Jactel.

Antiparasitics Food Animals

Boehringer's Zactran, MSD's Bravecto secure Japanese extensions

Boehringer Ingelheim Animal Health has secured Japanese approval for Zactran (gamithromycin) as an antibiotic treatment of swine respiratory disease.

Japan Boehringer Ingelheim Animal Health

Bayer to work with Mitsui on new antiparasitic compounds

Bayer Animal Health has teamed up with Japanese firm Mitsui Chemicals Agro (MCAG) in its search for novel parasite prevention.

Deals R&D
See All
Advertisement
UsernamePublicRestriction

Register